Free Trial

Medpace Q2 2023 Earnings Report

Medpace logo
$340.78 -4.07 (-1.18%)
As of 02/21/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Medpace EPS Results

Actual EPS
$1.93
Consensus EPS
$1.90
Beat/Miss
Beat by +$0.03
One Year Ago EPS
$1.46

Medpace Revenue Results

Actual Revenue
$460.90 million
Expected Revenue
$433.75 million
Beat/Miss
Beat by +$27.15 million
YoY Revenue Growth
+31.20%

Medpace Announcement Details

Quarter
Q2 2023
Time
After Market Closes

Conference Call Resources

Medpace Earnings Headlines

William Blair Has Bullish Forecast for Medpace Q1 Earnings
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
What is William Blair's Forecast for Medpace Q3 Earnings?
See More Medpace Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Medpace? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medpace and other key companies, straight to your email.

About Medpace

Medpace (NASDAQ:MEDP) engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

View Medpace Profile

More Earnings Resources from MarketBeat